Josh Berlin

I help biopharma leaders & investors build cross-border relationships in the U.S., Europe, and Asia. Retweets are not endorsements.

[Josh Berlin @BioPharmaJosh]

Partnering opens next week for 3rd BioCentury Grand Rounds-U.S. (June 3-5, Seattle). Join us to debate key bottlenecks in translation and how to make early-stage R&D investible. I hope to see you there! https://t.co/i8JDsdwRx6

[Josh Berlin @BioPharmaJosh]

Apparently, China biotech is even winning now on hot dogs.... :) https://t.co/tK7kr1qboG #ASCO2026

[Josh Berlin @BioPharmaJosh]

@jrkelly @PearlF @davidycli @daphnezohar @FishburnSimone @steveusdin1 I've seen everyone I know, with a few exceptions, under estimate China's ability to innovate in biopharma.

[Josh Berlin @BioPharmaJosh]

@PearlF @jrkelly @davidycli @daphnezohar @FishburnSimone @steveusdin1 My take: You must compete on innovation. Yes, US policy reforms are needed. Biopharmas must get into clinic faster to de-risk assets. But if you think China won't fix reimbursement, with 4x the patients of US, you aren't serious. I've seen it over and over for 20+ years.

[Josh Berlin @BioPharmaJosh]

Last Call: Advanced Rate Discount. 26th #BioEquityEurope. Register or apply to present by April 2 to lock in the price. No biotech event has a higher concentration of investors. Visit our website to see the full list of faculty (including ones below). https://t.co/SnhhaDMIjq

[Josh Berlin @BioPharmaJosh]

In 2 weeks @BioCentury is in Seoul for our 5th East-West Summit
→ Networking, partnering, debate
→ Biotechs/VCs from Korea, China, Japan, Singapore & beyond
→ @McKinsey conf report
→ Overnight Daejeon tour: See Korea's innovation moment for yourself
https://t.co/EWwrE516s0

[Josh Berlin @BioPharmaJosh]

@MattGardnerBio @BioCentury @CBRE Hah! The #WorldSockTour is something I can get behind! Great seeing you.

[Josh Berlin @BioPharmaJosh]

Hope to see you next week in Boston/Cambridge!

[BioCentury @BioCentury]

Watch a live recording of the "BioCentury this Week" podcast in Boston/Cambridge next week!

Plus, meet Korea biotechs looking for cross-border deals.

🗓️Thursday, Nov. 6 at Venture Cafe Cambridge, during KHIDI's K-Blockbuster Night.

✅ RSVP: https://t.co/xMe6rYjdx0

[Josh Berlin @BioPharmaJosh]

Don't be late to the Korea story.

Join @BioCentury, BayHelix, Insights Partner @McKinsey and Regional Host Chair @bio_korea in Seoul, March 9-11, for our 5th East-West Biopharma Summit -- focused on Asia's emerging Arc of Innovation.

✅ Register: https://t.co/EWwrE51Ehy

[Josh Berlin @BioPharmaJosh]

Partnering is open for BioCentury's 12th China Healthcare Summit (Shanghai, Oct. 22-24). Please send a DM if you have questions. Hope to see you there!

Check out the agenda: https://t.co/LJSo41G0aZ

#BioCenturyChinaSummit #biotech #pharma #dealmaking

[Josh Berlin @BioPharmaJosh]

Last call! Join @BioCentury Grand Rounds (Cambridge, UK, Sept. 17-19): Debate how to make early-stage R&D investible.

➣ Partnering is open
➣ Sold-out Presenting Company Track
➣ Sold-out Academic Poster Session
➣ Agenda: https://t.co/ErZrz4uOFv

#BioCenturyGrandRounds

[BioCentury @BioCentury]

Biotech IPOs, FDA-Stealth & patent threat — on the latest #BioCenturyThisWeek podcast with @SteveUsdin1 @BioPharmaJosh @BioBonanos @Jeff_Cranmer https://t.co/rr7JSgyCvn

[Josh Berlin @BioPharmaJosh]

Advanced Rate Discount ends Aug. 15 for Grand Rounds-Europe (Cambridge, UK, Sept. 17-19).

This BioCentury conference focused on key bottlenecks in translation and how to make early-stage R&D investible.

Register: https://t.co/ErZrz4uOFv

Hope to see you there!

[BioCentury @BioCentury]

Asia deals: Globalization is open for business. An analysis of 198 Asia deals in the last 2.5 years finds Western biotechs are engaging even more than pharmas. A breakdown of deal values, therapeutic areas, modalities and first-in-class potential. https://t.co/qweCpSj0PM

[BioCentury @BioCentury]

A new way of thinking about academia-industry collaboration — a special #BioCenturyGrandRounds edition of the #BioCenturyThisWeek podcast featuring @FishburnSimone & @BioPharmaJosh, top BioCentury analysts and special guests https://t.co/9rpAoGkcJh

[Josh Berlin @BioPharmaJosh]

Debate key bottlenecks in translation.

Join us June 4-6 in Chicago (after #ASCO25) for 2nd BioCentury Grand Rounds R&D Conference.

We will also host a European edition, Sept. 17-19, Cambridge, U.K.

Hope to see you there! #BioCenturyGrandRounds

https://t.co/i8JDsdwRx6

[Josh Berlin @BioPharmaJosh]

Looking for investors? No #biotech event attracts more VCs than #BioEquityEurope.

Join us May 12-14 in Bruges, Belgium, to celebrate the 25th edition of this destination event for CEOs and investors. https://t.co/hnz5478ARG

[Josh Berlin @BioPharmaJosh]

Early Bird for BioCentury's 4th East-West Biopharma Summit ends Dec. 31.

Join us in Singapore, March 2025, for a #biotech CEO & Investor conference focused on the emerging Arc of Innovation across Asia.

✅Register: https://t.co/EWwrE516s0

#BioCenturyEastWest

[Josh Berlin @BioPharmaJosh]

Are you attending London Life Sciences Week?

If so, join @BioCentury and @BIA_UK Nov. 19 (5pm-9pm) for our 2nd CEO and Investor Dialogue and networking reception. Includes fireside chat w/ @EricTokat of Centerview.

https://t.co/o4DCLoSc3f

Hope to see you there! #LLSW2024

[Josh Berlin @BioPharmaJosh]

It was great joining the BioCentury This Week podcast to talk shop with ⁦@jeff_cranmer⁩ about our 11th China Healthcare Summit + Cincinnati chili, Kentucky bourbon & Bengals/Ravens - How about that list?

Give a listen on your morning run or walk! https://t.co/QZz5g0U2tx